Explore detailed information on the case number ORD_10396/2024 involving Sanofi Aventis Groupe, Sanofi Winthrop Industrie, Sanofi Aventis Deutschland and Amgen which was filed on 27 Feb, 2024.

Case Details

    Case Number:

    ORD_10396/2024

    Filing Date:

    27 Feb, 2024

    Proceeding Type:

    Order

    Action/Application:

    Generic Order

    Plaintiffs:

    • Sanofi-Aventis Groupe
    • Sanofi Winthrop Industrie S.A
    • Sanofi-Aventis Deutschland Gmbh

    Defendants:

    • Amgen, Inc

Case Decision

Decision pending - set alert to receive updates

More cases on Sanofi Aventis Groupe

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Aug 21, 2025
Case NumberFiling DatePlaintiffsDefendants
ORD_39859/2024Jul 4, 2024Sanofi Aventis Groupe, Sanofi Aventis Deutschland, Sanofi Winthrop IndustrieAmgen
ORD_39859/2024Jul 4, 2024Sanofi Aventis Groupe, Sanofi Aventis Deutschland, Sanofi Winthrop IndustrieAmgen
APL_572929/2023Sep 13, 2023Sanofi-Aventis Groupe S.A., Regeneron Pharmaceuticals Inc., Sanofi Winthrop Industrie S.A., Sanofi-Aventis Deutschland GmbhAmgen Inc.

More cases on Amgen

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Aug 21, 2025
Case NumberFiling DatePlaintiffsDefendants
APL_32715/2025Jul 14, 2025Regeneron Pharmaceuticals, Sanofi BiotechnologiesAmgen, Amgen, Amgen Europe, Amgen, Amgen, Amgen, Amgen
APL_32715/2025Jul 14, 2025Regeneron Pharmaceuticals, Sanofi BiotechnologiesAmgen, Amgen, Amgen Europe, Amgen, Amgen, Amgen, Amgen
APL_32715/2025Jul 14, 2025Regeneron Pharmaceuticals, Sanofi BiotechnologiesAmgen, Amgen, Amgen Europe, Amgen, Amgen, Amgen, Amgen